WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...

A new injectable drug known as lenacapavir could change how millions of people across the world and Africa in particular access HIV protective drugs, which historically have hard to come by.

WHO recommends twice-yearly injectable lenacapavir for HIV prevention, expanding PrEP options for key populations.

A BREAKTHROUGH HIV drug that only needs to be injected twice a year to offer near-total protection from the virus and ...

Globally, an estimated 4,000 adolescent girls and young women become infected with HIV each week, with sub-Saharan Africa accounting for more than 60% of these new infections, according to the World ...

Tamar Braxton has announced a new brand partnership with Gilead Sciences. The music veteran will help educate and raise ...

South Africa will buy lenacapavir using Global Fund money. Studies show it can stop infections entirely in young women. But ...

Platinum prices have hit their highest level since August 2014, with spot platinum gaining by 0.1% to $1,458.80 per ounce on ...

In rural India, mycetoma—a painful, neglected disease from minor wounds—cripples workers, causing disability, poverty, and stigma. Delayed diagnosis and costly treatment worsen the crisis.

The WHO has approved the use of a new drug to prevent HIV. The drug is called Lenacapavir, and what makes it unique is that ...